Biomedical Textiles Market Research Report Information By Fiber Type (Non-Biodegradable, Biodegradable), Fabric Type (Woven, Non-Woven), Product Type (Non-Implantable, Implantable), Applications (Dentistry, General Surgery & Treatment), Region – Forecast Till 2032

Biomedical Textiles Market Overview

Biomedical Textiles Market Size was valued at USD 17.63 billion in 2023. The Biomedical Textiles Market industry is projected to grow from USD 18.72 Billion in 2024 to USD 30.30 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period (2024 - 2032). Biomedical textiles are fabrics that have been specifically created for use in biological conditions. The biocompatibility of these fabrics with biological cells, tissue, and fluids determines their performance. They are part of the medical textiles branch of the technical textiles department. Non-toxic, non-carcinogenic, non-allergic biomedical textiles should be sterilized, chemically inert, biocompatible, high strength, flexible, and have outstanding durability. End-use applications for biomedical textiles include ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and therapy, and others. Healthcare and hygiene items, non-implantable products, implantable products, and extracorporeal devices are all examples of biomedical textiles in use. Surgical garments, surgical drapes, beddings, sanitary napkins, baby diapers, adult incontinence products, and other healthcare and hygiene goods are used to protect healthcare staff and patients from contamination by blood and other infectious fluids. Non-implantable goods are used to provide protection against infection, absorption and exudation of blood and excess fluids, and healing applications through external application to the body with or without skin contact. Over the projected period, the global biomedical textiles market is expected to be driven by expanding healthcare budgets, rising health awareness, and rising healthcare expenditure.

Biomedical Textiles Market Key Players

Some of the prominent players in the global biomedical textiles market are Secant Group, LLC (U.S.), Confluent Medical Technologies (U.S.), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Meister & Cie AG (Switzerland), Cardinal Health. (U.S.), Smith & Nephew (UK), Medline Industries, Inc (India), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), BSN medical. (Germany), B. Braun Melsungen AG (Germany), 3M (U.S.), Elkem Silicones (Norway), and ATEX TECHNOLOGIES (U.S.).

Global Biomedical Textiles Market Share in 2017, by Product Type

 

Source: MRFR Analysis

Market Segmentation

The global biomedical textiles market is segmented by fiber type, fabric type, product type, application, and region.

On the basis of the fiber type, the global biomedical textiles market is segmented into the non-biodegradable fiber and biodegradable fiber.  Non-biodegradable fiber is sub-segmented into polypropylene, polyethylene, polyester, polyamide, polyurethane, polytetrafluoroethylene, and others. Biodegradable fiber is sub-segmented into cotton, viscose rayon, collagen, chitin, and others.

On the basis of the fabric type, the global biomedical textiles market is segmented into woven, non-woven, knitted & braided fabrics, hollow fabric, and others.

On the basis of the product type, the global biomedical textiles market is segmented into healthcare & hygiene products, non-implantable products, implantable products, and extracorporeal devices. Healthcare & hygiene products are sub-segmented into surgical clothing, surgical drapes, beddings, sanitary napkins, baby diapers, adult incontinence products, and others. Non-implantable products are sub-segmented into bandages, wound care dressings, plasters, gauze, and others. Implantable products are sub-segmented into soft tissue implants (hernia repair, ligament implant), hard tissue implants (orthopedic implant, dental implant), cardiovascular implants (vascular graft, heart valve), surgical sutures, and others. Extracorporeal devices are sub-segmented into artificial kidney, liver, and lungs.

Based on applications, the global biomedical textiles market is segmented into ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery & treatment, and others.

Regional Analysis

The global biomedical textiles market is segmented into five regions namely Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. 

Asia Pacific was a lucrative market for biomedical textiles in 2017 and is expected to witness a considerable demand during the forecast period. A large population base in Asia Pacific drives the strong need for healthcare facilities to combat cases of the aging population, rising cases of chronic & lifestyle diseases, accident cases; this is likely to boost demand of biomedical textiles in healthcare industry during the forecast period. Additionally, growing foreign investments in healthcare sector due to relaxed investments norms as well as various government initiatives such as high budget allocation for healthcare sector is likely to impact the healthcare industry positively and thus are expected to surge the demand for biomedical textiles over the forecast period.

North America and Europe market are relatively mature and are expected to witness steady demand for biomedical textiles owing to the limited growth scope during the forecast period.

The Middle East & Africa is expected to witness rising demand for biomedical textiles mostly from GCC countries owing to their growing healthcare expanding projects to strengthen the industry during the forecast period.

Latin America is expected to witness a moderate growth over the forecast period. Brazil healthcare industry is expected to drive the largest demand for biomedical textiles, followed by a demand from Mexico, Chile, Peru, and Columbia country.

Biomedical Textiles Market Industry Developments

• Q2 2024: Confluent Medical Technologies Announces Expansion of Biomedical Textile Manufacturing Facility in Costa Rica Confluent Medical Technologies opened a new, expanded biomedical textile manufacturing facility in Costa Rica to increase production capacity for implantable medical textiles used in cardiovascular and orthopedic devices.
• Q1 2024: Secant Group Launches Regenerez™ Bioabsorbable Textile Platform for Regenerative Medicine Secant Group introduced Regenerez™, a new bioabsorbable textile platform designed for use in regenerative medicine applications, expanding its biomedical textile product portfolio.
• Q2 2024: DSM Biomedical and Terumo Aortic Announce Strategic Partnership for Textile-Based Vascular Grafts DSM Biomedical entered a strategic partnership with Terumo Aortic to co-develop advanced textile-based vascular grafts, leveraging DSM’s biomedical textile technology for next-generation cardiovascular implants.
• Q3 2024: Poly-Med, Inc. Receives FDA 510(k) Clearance for Biofelt™ Absorbable Textile Scaffold Poly-Med, Inc. received FDA 510(k) clearance for its Biofelt™ absorbable textile scaffold, enabling commercialization of the product for soft tissue repair and regenerative medicine applications.
• Q2 2024: Freudenberg Medical Expands Biomedical Textile Production with New Facility in Massachusetts Freudenberg Medical opened a new manufacturing facility in Massachusetts dedicated to the production of biomedical textiles for implantable medical devices, aiming to meet growing demand in the U.S. market.
• Q1 2025: Medtronic Acquires Textile-Based Hernia Mesh Startup Synovis for $150 Million Medtronic completed the acquisition of Synovis, a startup specializing in textile-based hernia mesh implants, to strengthen its surgical solutions portfolio.
• Q2 2025: B. Braun Launches New Line of Antimicrobial Surgical Sutures Using Advanced Textile Technology B. Braun introduced a new line of antimicrobial surgical sutures made with advanced biomedical textile technology, targeting infection reduction in surgical procedures.
• Q1 2024: Stryker Announces $100 Million Investment in Biomedical Textile R&D Center Stryker announced a $100 million investment to establish a new research and development center focused on biomedical textiles for orthopedic and soft tissue repair devices.
• Q3 2024: Cardinal Health Signs Multi-Year Supply Agreement for Implantable Textile Mesh with Advanced Medical Solutions Cardinal Health entered a multi-year supply agreement with Advanced Medical Solutions to source implantable textile mesh for use in surgical and wound care products.
• Q2 2025: Integra LifeSciences Receives CE Mark for New Textile-Based Dura Substitute Integra LifeSciences received CE Mark approval for its new textile-based dura substitute, allowing commercialization in the European Union for neurosurgical applications.
• Q1 2025: Lydall Invests $50 Million in Expansion of Biomedical Textile Operations in North Carolina Lydall announced a $50 million investment to expand its biomedical textile manufacturing operations in North Carolina, increasing capacity for medical implant and wound care products.
• Q2 2024: Avient Corporation Launches New Biocompatible Textile Fiber for Implantable Medical Devices Avient Corporation launched a new biocompatible textile fiber designed for use in implantable medical devices, expanding its offerings in the biomedical textiles sector.

Intended Audience

• Biomedical textiles manufacturers
• Traders and distributors of biomedical textiles
• Research and development institutes
• Potential investors
• Raw material suppliers
• Nationalized laboratory

Report Attribute/Metric	Details
Market Size 2023	USD 17.63 billion
Market Size 2024	USD 18.72 billion
Market Size 2032	USD 30.30 billion
Compound Annual Growth Rate (CAGR)	6.4% (2024 - 2032)
Base Year	2023
Forecast Period	2024 - 2032
Historical Data	2019 & 2020
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	fiber type, fabric type, product type and application
Geographies Covered	Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa.
Countries Covered	The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Secant Group, LLC (U.S.), Confluent Medical Technologies (U.S.), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Meister & Cie AG (Switzerland), Cardinal Health. (U.S.), Smith & Nephew (UK), Medline Industries, Inc (India), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), BSN medical. (Germany), B. Braun Melsungen AG (Germany), 3M (U.S.), Elkem Silicones (Norway), and ATEX TECHNOLOGIES (U.S.).
Key Market Opportunities	Huge market scope for biomedical textiles in the healthcare industry
Key Market Dynamics	Growing healthcare industry on account of rising healthcare budget, growing health awareness, and rising healthcare expenditure is likely to drive the global biomedical textiles industry